Detalhe da pesquisa
1.
In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypes.
Cancer Immunol Immunother
; 69(11): 2179-2191, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472369
2.
Pembrolizumab as first line treatment of Merkel cell carcinoma patients - a case series of patients with various co-morbidities.
Acta Oncol
; 59(7): 793-796, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285728
3.
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma.
Oncoimmunology
; 13(1): 2290900, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38125722
4.
Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma.
Clin Cancer Res
; 29(17): 3320-3328, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382656
5.
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.
J Transl Med
; 10: 169, 2012 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22909342
6.
Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures.
Cell Immunol
; 273(1): 1-9, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22230732
7.
The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor.
Cancers (Basel)
; 14(23)2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36497235
8.
Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment.
Oncogene
; 41(9): 1364-1375, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35017664
9.
Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.
Cytotherapy
; 13(7): 822-34, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21428850
10.
[Merkel cell carcinoma].
Ugeskr Laeger
; 183(30)2021 07 26.
Artigo
em Dinamarquês
| MEDLINE | ID: mdl-34356025
11.
Therapeutic cancer vaccines in combination with conventional therapy.
J Biomed Biotechnol
; 2010: 237623, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20617155
12.
Management Recommendations for Merkel Cell Carcinoma-A Danish Perspective.
Cancers (Basel)
; 12(3)2020 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32121063
13.
The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines.
Cancer Immunol Immunother
; 58(5): 665-75, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18828018
14.
Severely Disseminated Kaposi Sarcoma after ABO-Incompatible Kidney Transplantation Treated Successfully with Paclitaxel and Gemcitabine Combined with Hemodialysis.
Case Rep Transplant
; 2019: 8105649, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31886011
15.
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine.
Oncoimmunology
; 5(8): e1202391, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622072
16.
Dissection of T-cell antigen specificity in human melanoma.
Cancer Res
; 72(7): 1642-50, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22311675
17.
Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application.
J Skin Cancer
; 2011: 574695, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21773037
18.
The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase.
PLoS One
; 4(9): e6910, 2009 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-19738905
19.
A promiscuous survivin-derived T-cell epitope restricted to the HLA-A3 super-type alleles.
J Invest Dermatol
; 132(8): 2115-8, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22513782
20.
[Biphosphonates in breast cancer--based on a Cochrane meta-analysis]. / Bisfosfonater ved brystkraeft--baseret på en Cochrane-metaanalyse.
Ugeskr Laeger
; 169(37): 3108-11, 2007 Sep 10.
Artigo
em Dinamarquês
| MEDLINE | ID: mdl-17877961